CareCloud, Inc. (CCLD) 股票分析

公司概述

CareCloud, Inc. operates as a healthcare information technology enterprise that delivers technology-enabled business solutions and Software-as-a-Service offerings to healthcare providers and hospitals, primarily within the United States. The company functions within the Healthcare sector, specifically targeting the Health Information Services industry, which focuses on the digitization and management of patient data and operational workflows for medical institutions. On a macroeconomic scale, the company possesses a market capitalization of $117.28 million and generates $120.50 million in trailing twelve-month revenue, supported by a workforce of 3,650 employees. These valuation and revenue figures indicate that CareCloud maintains a mid-cap status, suggesting it has established a significant operational footprint but remains sensitive to sector-specific regulatory changes and technology adoption rates that often characterize smaller to medium-sized players in the health IT landscape.

财务健康

The company reported a trailing twelve-month revenue of $120.50 million with a corresponding net income of $3.89 million and an EBITDA of $16.39 million, revealing a substantial gap between gross earnings and bottom-line profit that highlights the company's cost structure and operational expense intensity. The entity generated free cash flow of $18.23 million, which signifies a robust capacity to fund capital expenditures, service debt obligations, or pursue strategic acquisitions without requiring external equity financing. Gross margin stands at 46.5%, reflecting the pricing power and efficiency of the company's service delivery model, while an operating margin of 9.1% and a profit margin of 9.0% demonstrate the effectiveness of cost control measures in converting revenue into operational and net earnings. On the balance sheet, CareCloud holds $3.12 million in cash against $4.28 million in debt, resulting in a debt-to-equity ratio of 7.20, which indicates a highly leveraged financial position where equity capital is relatively thin compared to long-term liabilities. Liquidity is assessed via a current ratio of 1.05, suggesting that the company's current assets are only marginally higher than its current liabilities, implying a tight working capital environment that requires careful management of short-term obligations. Furthermore, the return on equity is 19.8% and the return on assets is 9.0%, metrics that reveal management's ability to generate high returns on the shareholders' invested capital relative to the total asset base, despite the leverage present on the balance sheet.

估值评估

Valuation metrics for CareCloud show a trailing P/E ratio of 27.60 compared to a forward P/E of 7.26, implying that the market currently prices in significantly higher expected earnings growth than the historical average or that current earnings are depressed relative to future projections. The price-to-book ratio is 1.97, indicating that the stock trades at a premium of nearly double its book value, which may reflect investor confidence in the intangible assets of the health IT business or expectations of sustained profitability above the asset base. Alternative valuation measures include a price-to-sales ratio of 0.97 and an EV/EBITDA of 7.23, suggesting the company is valued at roughly equal to one year of sales and slightly more than one year of adjusted earnings before interest, taxes, depreciation, and amortization. Price volatility is captured by a 52-week high of $4.01 and a 52-week low of $1.15, meaning the current trading price sits at a level that requires calculation against these bounds to determine its relative discount or premium to the recent price range. The beta value of 1.83 indicates that the stock exhibits substantially higher price volatility than the broader market, moving with greater magnitude in response to market-wide shifts or sector-specific news.

Growth & Income

Revenue growth accelerated by 21.9% year-over-year, while earnings growth is listed as N/A due to the absence of comparable prior period data in the provided facts, preventing a direct comparison of earnings expansion rates against revenue expansion. As a non-dividend payer, the company maintains a dividend yield of N/A and a payout ratio of 0.0%, indicating that management chooses to reinvest all net income into business expansion, technology development, or balance sheet strengthening rather than distributing cash to shareholders. This reinvestment strategy aligns with the capital-intensive nature of the health IT sector where funding R&D and scaling infrastructure is often prioritized over immediate income distribution. The overall growth and income profile for CareCloud is characterized by aggressive top-line expansion and zero dividend distribution, presenting a capital appreciation play rather than an income investment opportunity.